At Quotient Sciences we have supported over 50 development programs for rare diseases in the past 5 years. Our extensive formulation know-how, and clinical pharmacology expertise, coupled with our agile and flexible approach to clinical manufacturing and commercial manufacturing, make us the ideal partner.
From pre-formulation and formulation development through clinical development and scale-up for commercial manufacturing, we provide an end-to-end solution for the development of orphan drug products. Our extensive expertise and capabilities for orphan drug development include:
Related content